Skip to main content
Log in

Continuous pulse oximetry for patients receiving opioids may be cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Funded by Medtronic.

Reference

  • Khanna AK, et al. Modeling the Cost Savings of Continuous Pulse Oximetry and Capnography Monitoring of United States General Care Floor Patients Receiving Opioids Based on the PRODIGY Trial. . Advances in Therapy : 24 May 2021. Available from: URL: http://doi.org/10.1007/s12325-021-01779-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Continuous pulse oximetry for patients receiving opioids may be cost effective. PharmacoEcon Outcomes News 880, 5 (2021). https://doi.org/10.1007/s40274-021-7763-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7763-3

Navigation